Healthcare provider profile · identity verified

Robert Bryant

Family Practice · PIEDMONT, SC · NPI 1114331154

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Montelukast Sodium	Montelukast Sodium	384	116
Atorvastatin Calcium	Atorvastatin Calcium	325	97
Famotidine	Famotidine	217	72
Omeprazole	Omeprazole	215	57
Amlodipine Besylate	Amlodipine Besylate	198	55
Albuterol Sulfate Hfa	Albuterol Sulfate	175	68
Gabapentin	Gabapentin	174	44
Losartan Potassium	Losartan Potassium	166	51
Levothyroxine Sodium	Levothyroxine Sodium	161	51
Alprazolam	Alprazolam	132	18
Fluticasone Propionate	Fluticasone Propionate	127	62
Rosuvastatin Calcium	Rosuvastatin Calcium	125	41
Lisinopril	Lisinopril	108	31
Prednisone	Prednisone	101	73
Glipizide Er	Glipizide	95	26
Mounjaro	Tirzepatide	94	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	23
Pantoprazole Sodium	Pantoprazole Sodium	87	29
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	85	15
Carvedilol	Carvedilol	79	19
Furosemide	Furosemide	70	25
Metformin Hcl	Metformin Hcl	69	19
Metoprolol Succinate	Metoprolol Succinate	69	24
Pravastatin Sodium	Pravastatin Sodium	69	21
Trazodone Hcl	Trazodone Hcl	68	26
Buspirone Hcl	Buspirone Hcl	66	19
Duloxetine Hcl	Duloxetine Hcl	65	21
Meloxicam	Meloxicam	64	27
Tamsulosin Hcl	Tamsulosin Hcl	63	25
Tizanidine Hcl	Tizanidine Hcl	60	20
Zolpidem Tartrate	Zolpidem Tartrate	60	suppressed
Eliquis	Apixaban	59	12
Sertraline Hcl	Sertraline Hcl	57	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	19
Hydroxyzine Hcl	Hydroxyzine Hcl	53	24
Diclofenac Sodium	Diclofenac Sodium	52	19
Hydrochlorothiazide	Hydrochlorothiazide	50	19
Fluoxetine Hcl	Fluoxetine Hcl	48	11
Rybelsus	Semaglutide	48	suppressed
Ozempic	Semaglutide	47	11
Propranolol Hcl Er	Propranolol Hcl	47	14
Celecoxib	Celecoxib	46	30
Simvastatin	Simvastatin	46	14
Alendronate Sodium	Alendronate Sodium	45	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	12
Temazepam	Temazepam	41	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	11
Metformin Hcl Er	Metformin Hcl	38	13
Nortriptyline Hcl	Nortriptyline Hcl	38	16
Mirtazapine	Mirtazapine	36	11
Naproxen	Naproxen	36	14
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Spironolactone	Spironolactone	36	13
Promethazine Hcl	Promethazine Hcl	35	suppressed
Bupropion Xl	Bupropion Hcl	34	13
Ondansetron Odt	Ondansetron	33	19
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Pregabalin	Pregabalin	32	12
Topiramate	Topiramate	32	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Meclizine Hcl	Meclizine Hcl	29	13
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	28	11
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Potassium Chloride	Potassium Chloride	28	11
Valacyclovir	Valacyclovir Hcl	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	11
Diazepam	Diazepam	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Cephalexin	Cephalexin	25	18
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Levofloxacin	Levofloxacin	25	18
Linzess	Linaclotide	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Fluconazole	Fluconazole	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Torsemide	Torsemide	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	20
Aripiprazole	Aripiprazole	20	suppressed
Creon	Lipase/Protease/Amylase	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Naloxone Hcl	Naloxone Hcl	17	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Acarbose	Acarbose	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Ibuprofen	Ibuprofen	16	suppressed
Mupirocin	Mupirocin	16	16
Novolog Flexpen	Insulin Aspart	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Vraylar	Cariprazine Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Atenolol	Atenolol	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Valsartan	Valsartan	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Baclofen	Baclofen	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error